Drs. Dinesh Khanna, FitzGerald, and Puja P. Khanna contributed equally to this work.
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Version of Record online: 28 SEP 2012
Copyright © 2012 by the American College of Rheumatology
Arthritis Care & Research
Volume 64, Issue 10, pages 1431–1446, October 2012
How to Cite
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., Kaldas, M., Gogia, M., Perez-Ruiz, F., Taylor, W., Lioté, F., Choi, H., Singh, J. A., Dalbeth, N., Kaplan, S., Niyyar, V., Jones, D., Yarows, S. A., Roessler, B., Kerr, G., King, C., Levy, G., Furst, D. E., Edwards, N. L., Mandell, B., Schumacher, H. R., Robbins, M., Wenger, N. and Terkeltaub, R. (2012), 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res, 64: 1431–1446. doi: 10.1002/acr.21772
- Issue online: 28 SEP 2012
- Version of Record online: 28 SEP 2012
- Manuscript Accepted: 15 JUN 2012
- Manuscript Received: 9 JAN 2012
- American College of Rheumatology
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH. Grant Number: K24-AR-063120
Additional Supporting Information may be found in the online version of this article.
|ACR_21772_sm_SupplFig1.pdf||83K||Supplementary Figure 1|
|ACR_21772_sm_SupplFig2.pdf||66K||Supplementary Figure 2|
|ACR_21772_sm_SupplFig3.doc||30K||Supplementary Figure 3|
|ACR_21772_sm_SupplFig4.pdf||61K||Supplementary Figure 4|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.